• Home>
  • Stocks>
  • Emmessar Biotech & Nutrition Ltd Share Price
Emmessar Biotech & Nutrition Ltd share price logo

Emmessar Biotech & Nutrition Ltd Share Price

BSE: 524768

Small Cap

Chemical Sector

₹30.99

+1.24

(+4.17%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Emmessar Biotech & Nutrition Ltd Stock Performance

as on November 7, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹28.32
    ₹31.22
    downward going graph

    8.62%

    Downside

    0.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹25.8
    ₹64
    downward going graph

    16.75%

    Downside

    106.52%

    Upside

    downward going graph

Emmessar Biotech & Nutrition Ltd share price movements today

Previous Close
₹29.75
Open
₹31.22
Volume
565.00
Upper Circuit
₹31.23
Lower Circuit
₹28.27
Day's Low - High
₹28.32 - ₹31.22
52 Week Low - High
₹25.8 - ₹64

Emmessar Biotech & Nutrition Ltd Historical Returns

1 Month Return
-6.56 %
3 Month Return
+ 8.62 %
1 Year Return
-47.2 %
3 Year Return
+ 32.22 %
5 Year Return
+ 103.91 %

Emmessar Biotech & Nutrition Ltd Fundamentals

as on November 7, 2025 at 4:01 pm IST

Market Cap

₹14.88 Cr

Return on Equity (ROE)

4.23

PE Ratio (TTM)

0

Return on capital employed (ROCE)

11.52

Beta (LTM)

0.88

P/B Ratio

1.97

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

88.89

EPS (TTM)

0

Sector

Chemicals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Emmessar Biotech & Nutrition Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Emmessar Biotech & Nutrition Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Emmessar Biotech & Nutrition Ltd image
Emmessar Biotech & Nutrition Ltd
NA14.8820.78%0.0011
Shreyas Intermediates Ltd image
Shreyas Intermediates Ltd
NA53.072.46%0.00-2NA
Indo Borax & Chemicals Ltd image
Indo Borax & Chemicals Ltd
NA786.3713.14%0.5038191
Unilex Colour & Chemical Ltd image
Unilex Colour & Chemical Ltd
NA55.83-10.7%0.006151
IEL Ltd image
IEL Ltd
NA106.14173.81%0.0026
See all

Emmessar Biotech & Nutrition Ltd Stock’s Investor Sentiment and Interest

Search interest for Emmessar Biotech & Nutrition Ltd Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Emmessar Biotech & Nutrition Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
0.43
0.32
0.07
0.08
0.33
0.08
0.08
0.34
0.1
0.1
0.09
Other Income
0.44
0.42
0.46
0.53
0.53
0.48
0.46
0.51
0.43
0.61
0.53
Total Income
0.87
0.73
0.52
0.61
0.85
0.56
0.54
0.85
0.53
0.7
0.63
Expenses
0.6
0.47
0.34
0.3
0.53
0.47
0.35
0.42
0.38
0.42
0.37
Operating Profit
-0.17
-0.15
-0.27
-0.22
-0.2
-0.39
-0.27
-0.08
-0.28
-0.32
-0.28
Operating Profit Margin %
-39.53%
-46.87%
-385.71%
-275%
-60.61%
-487.5%
-337.5%
-23.53%
-280%
-320%
-311.11%
Profit Before Interest, Tax and Depreciation
0.27
0.26
0.18
0.31
0.32
0.09
0.18
0.43
0.15
0.28
0.26
Depreciation
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Profit Before Tax
0.25
0.24
0.16
0.29
0.3
0.07
0.16
0.41
0.13
0.26
0.24
Tax Paid
0.27
0.05
0.11
0.09
0.17
-0.2
0.07
0.13
0.11
0.33
0.06
Profit After Tax
-0.02
0.2
0.05
0.2
0.13
0.27
0.09
0.28
0.02
-0.07
0.17
Total Net profit including share of profit / Loss from associate company
-0.02
0.2
0.05
0.2
0.13
0.27
0.09
0.28
0.02
-0.07
0.17
EPS
-0.04
0.38
0.11
0.39
0.26
0.71
0.18
0.56
0.03
-0.16
0.34
Actual EPS
-0.04
0.38
0.11
0.39
0.26
0.71
0.18
0.56
0.03
-0.16
0.34
Adjusted EPS
-0.04
0.38
0.11
0.39
0.26
0.71
0.18
0.56
0.03
-0.16
0.34
Diluted EPS
-0.04
0.38
0.11
0.39
0.26
0.71
0.18
0.56
0.03
-0.16
0.34

Emmessar Biotech & Nutrition Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2.63
1.25
0.63
3.4
6.99
0.36
1.02
0.56
0.61
Other Income
0.98
1.27
1.3
1.47
1.47
1.92
1.75
1.99
2.01
Total Income
3.61
2.52
1.93
4.86
8.46
2.28
2.77
2.55
2.62
Expenses
2.4
1.67
1.56
4.07
6.14
1.26
1.71
1.64
1.56
Operating Profit
0.23
-0.42
-0.93
-0.67
0.85
-0.9
-0.69
-1.08
-0.95
Operating Profit Margin %
8.75%
-33.6%
-147.62%
-19.71%
12.16%
-250%
-67.65%
-192.86%
-155.74%
Profit Before Interest, Tax and Depreciation
1.2
0.85
0.37
0.8
2.31
1.02
1.06
0.91
1.06
Depreciation
0.01
0.05
0.08
0.06
0.06
0.09
0.09
0.1
0.1
Profit Before Tax
1.19
0.8
0.29
0.74
2.25
0.93
0.97
0.81
0.96
Tax Paid
-
-0.12
-0.24
-0.02
0.81
0.45
0.46
0.16
0.64
Profit After Tax
1.19
0.91
0.53
0.75
1.45
0.48
0.5
0.65
0.32
Total Net profit including share of profit / Loss from associate company
1.19
0.91
0.53
0.75
1.45
0.48
0.5
0.65
0.32
EPS
2.36
1.79
1.05
1.51
2.88
0.94
0.99
1.48
0.61
Actual EPS
2.36
1.79
1.05
1.51
2.88
0.94
0.99
1.48
0.61
Adjusted EPS
2.36
1.79
1.05
1.51
2.88
0.94
0.99
1.48
0.61
Diluted EPS
2.36
1.79
1.05
1.51
2.88
0.94
0.99
1.48
0.61

Emmessar Biotech & Nutrition Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.44
0.75
0.74
0.39
1.03
0.47
2.27
0.38
0.64
0.22
Cash Flow from Investing Activities
-0.46
0.06
-0.69
-0.37
-1.05
0.01
-2.62
-0.55
-0.64
-0.23
Net Cash Flow
-0.02
0.01
0.05
0.01
-0.03
0.48
-0.34
-0.17
-
-

Emmessar Biotech & Nutrition Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
58.53%
59.08%
59.33%
59.53%
59.53%
59.53%
59.53%
59.53%
59.53%
59.53%
59.53%
59.53%
DII
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
0.2%
Public
41.28%
40.73%
40.47%
40.28%
40.28%
40.28%
40.28%
40.28%
40.28%
40.28%
40.28%
40.28%
Total Outstanding Shares
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
49,96,100
Total Shareholders
7,024
6,933
6,874
6,822
6,844
7,146
6,900
6,936
7,186
7,180
7,173
7,350

Emmessar Biotech & Nutrition Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Emmessar Biotech & Nutrition Ltd.

  • Emmessar Biotech & Nutrition Ltd Earnings Results

    Emmessar Biotech & Nutrition Ltd’s net profit jumped 88.89% since last year same period to ₹0.17Cr in the Q1 2025-2026. On a quarterly growth basis, Emmessar Biotech & Nutrition Ltd has generated 342.86% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Emmessar Biotech & Nutrition Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 40.28% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 15.5% return, outperforming this stock by 62.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.3% return, outperforming this stock by 79.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.53% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, Emmessar Biotech stock has moved down by -17.7%

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech Nutrition Ltd (EBNL) started off as Emmessar Chemical Industries Ltd (ECIL) in March 1992 and soon gained recognition from the Ministry of Science and Technology in New Delhi, India. When they realised that their specialty chemicals were being used to produce healthcare formulations, the company saw a potential opportunity to enter this market. As evidence of their success in healthcare, they changed their name to Emmessar Biotech Nutrition Ltd which better represented their new core activity. Today their core business is Vital Micro Nutrients, through combining Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology, known as VedaCeuticals, to and address obstinate skin problems, chronic physical ailments and muscle/bone problems. The company has a paid-up share capital of 50 million rupees (approx. 1 million USD) and is listed on the Bombay Stock Exchange.

Revenue: ₹0.09Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.17Cr as on June 2025 (Q1 FY26)
Chairperson Name: MSR Ayyangar
OrganisationEmmessar Biotech & Nutrition Ltd
IndustryChemicals
CEOMSR Ayyangar
E-voting on sharesClick here to vote

FAQs

What is Emmessar Biotech & Nutrition Ltd share price today?

Emmessar Biotech & Nutrition Ltd share price today stands at ₹30.99 as on at the close of the market. Emmessar Biotech & Nutrition Ltd share today touched a day high of ₹31.22 and a low of ₹28.32.

What is the 52 week high and 52 week low range for Emmessar Biotech & Nutrition Ltd share?

Emmessar Biotech & Nutrition Ltd touched a 52 week high of ₹64 and a 52 week low of ₹25.8. Emmessar Biotech & Nutrition Ltd share price today i.e. is closed at ₹30.99, which is -51.58% down from its 52 week high and 20.12% up from its 52 week low.

What is Emmessar Biotech & Nutrition Ltd's market capitalisation today?

Emmessar Biotech & Nutrition Ltd market capitalisation is ₹14.88 Cr as on .

How to buy Emmessar Biotech & Nutrition Ltd shares?

To buy Emmessar Biotech & Nutrition Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524768 or Emmessar Biotech & Nutrition Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Emmessar Biotech & Nutrition Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Emmessar Biotech & Nutrition Ltd trading volume today?

Emmessar Biotech & Nutrition Ltd trading volume is 565.00 as on . This means that 565.00 shares of Emmessar Biotech & Nutrition Ltd were bought and sold on the stock market during today's trading session.